MHRA's New Regulatory Model: Accelerating Global Medical Technology Approvals from 2024

Starting in 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) will transition to an innovative regulatory model. This approach will expedite and streamline approvals for medical technologies, particularly those already sanctioned by reputable international regulators such as those in the US, Europe, and Japan.

Simultaneously, the MHRA will establish a rapid approval pathway for state-of-the-art medical devices, positioning the UK as a leading hub for their evolution.

Further bolstered by additional funding over the forthcoming two years, the MHRA aims to establish the world's fastest and simplest regulatory approval process for businesses seeking quick market access.

🔗 Original Document :  https://www.gov.uk/government/news/mhra-to-receive-10m-from-hm-treasury-to-fast-track-patient-access-to-cutting-edge-medical-products